Antibiotic resistance

Use of antibiotics in animals is decreasing

Retrieved on: 
Wednesday, June 30, 2021
Health sciences, Health, Medicine, Antibiotic resistance, Pharmaceuticals policy, Veterinary medicine, Evolutionary biology, Polymyxin, Antibiotic, Colistin, Bacteria, Antimicrobial

The significant fall in antibiotic use in food-producing animals suggests that the measures taken at country level to reduce use are proving to be effective.

Key Points: 
  • The significant fall in antibiotic use in food-producing animals suggests that the measures taken at country level to reduce use are proving to be effective.
  • Use of a class of antibiotics called polymyxins, which includes colistin, nearly halved between 2016 and 2018 in food-producing animals.
  • The report also identifies links between antimicrobial consumption in animals and AMR in bacteria from food-producing animals, which in turn is associated with AMR in bacteria from humans.
  • Experts found an association between resistance in these bacteria in animals and resistance in the same bacteria in humans.

EW Nutrition launches phytogenic solution for respiratory support in the Philippines

Retrieved on: 
Monday, June 21, 2021
Articles, Health sciences, Pharmaceuticals policy, Veterinary medicine, Evolutionary biology, Health, Antimicrobial resistance, Antibiotic resistance

SINGAPORE, June 21, 2021 /PRNewswire/ -- EW Nutrition, an international player in the animal nutrition industry, has revealed Grippozon as its respiratory health solution in the Philippines.

Key Points: 
  • SINGAPORE, June 21, 2021 /PRNewswire/ -- EW Nutrition, an international player in the animal nutrition industry, has revealed Grippozon as its respiratory health solution in the Philippines.
  • In conjunction with the launch of Grippozon, EW Nutrition hosted a webinar for customers in the Philippines.
  • Acting preventively against respiratory risks, Grippozon can improve welfare and respiratory ease, reduce the need for antibiotics, and consequently mitigate the risk of antimicrobial resistance.
  • EW Nutrition is an international animal nutrition company that offers integrators, feed companies, and self-mixing farmers comprehensive solutions for animal gut health, feed quality, growth performance, and more.

Researchers Discover Critical Role of Hydrogen Sulfide in Ability of Bacteria to Survive Antibiotics

Retrieved on: 
Thursday, June 10, 2021
Microbiology, Branches of biology, Medical specialties, Bacteriology, Antibiotic resistance, Bacteria, Persister cells, Biofilm, Antibiotic, Hydrogen sulfide

NEW YORK, June 10, 2021 /PRNewswire/ -- The signaling molecule hydrogen sulfide (H2S) plays a critical role in antibiotic tolerance, the innate ability of bacteria to survive normally lethal levels of antibiotics, a new study finds.

Key Points: 
  • NEW YORK, June 10, 2021 /PRNewswire/ -- The signaling molecule hydrogen sulfide (H2S) plays a critical role in antibiotic tolerance, the innate ability of bacteria to survive normally lethal levels of antibiotics, a new study finds.
  • In one defense mechanism, tolerant bacteria, also called "persisters," stop multiplying (proliferating), reducing their energy use (metabolism) to survive antibiotic treatment, but resuming growth when the treatment ends.
  • Persisters are particularly abundant in biofilms, bacterial colonies that live in tough polymeric matrices which further prevent their eradication.
  • "New approaches are urgently neededto preventthis, and our study suggeststhatsuppressing bacterial H2S would make different antibiotics more potent."

We Must Reduce the Misuse of Antibiotics

Retrieved on: 
Tuesday, June 1, 2021
Health sciences, Articles, Pharmaceuticals policy, Veterinary medicine, Health, Antibiotic resistance, Evolutionary biology, Antimicrobial resistance, Antibiotic misuse, Antibiotic, Antibiotic use in livestock

BALTIMORE, Md., June 1, 2021 /PRNewswire/ --Antibiotic resistance is a global health crisis, and it's fueled by theoveruse of antibiotics in livestock.

Key Points: 
  • BALTIMORE, Md., June 1, 2021 /PRNewswire/ --Antibiotic resistance is a global health crisis, and it's fueled by theoveruse of antibiotics in livestock.
  • More than 80% of antibiotics soldin the U.S. go to farm animals.
  • Tostrengthen our food systems, we mustreduce the misuse of antibiotics.
  • WHAT: A virtual panel discussing the misuse of antibiotics.

European $13.5 Billion Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activity and Route of Administration - Opportunity Analysis and Industry Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 20, 2021
Health, Pharmaceutical, Health sciences, Articles, Health, Pharmaceuticals policy, Veterinary medicine, Antibiotic resistance, Evolutionary biology, Antimicrobial resistance, Antibiotic misuse, Antibiotic, Drug resistance, Antibiotic use in livestock

b'The "European Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activity and Route of Administration: Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com\'s offering.\nThe European antibiotics market was valued at $11,561 million in 2019, and is projected to reach $13,529 million by 2027 at a CAGR of 1.9% from 2020 to 2027.\nThere is an increase in the demand for antibiotics, owing to rise in prevalence of infectious diseases.

Key Points: 
  • b'The "European Antibiotics Market by Drug Class, Drug Origin, Spectrum of Activity and Route of Administration: Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com\'s offering.\nThe European antibiotics market was valued at $11,561 million in 2019, and is projected to reach $13,529 million by 2027 at a CAGR of 1.9% from 2020 to 2027.\nThere is an increase in the demand for antibiotics, owing to rise in prevalence of infectious diseases.
  • In addition, development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials further drive the market growth.\nHowever, development of antibiotic resistance, driven by misuse of antibiotics and the time taken for the regulatory approval is projected to impede the market growth.\nOn the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.\n'

Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, May 17, 2021
Health, Articles, Antibiotic resistance, Antimicrobial stewardship, Health care quality, Cision, Antimicrobial, Health care

b'TORONTO, May 17, 2021 /PRNewswire-PRWeb/ --The implementation process for rapid molecular blood culture identification can be a complex process for laboratories, medical staff and the antimicrobial stewardship program (ASP).

Key Points: 
  • b'TORONTO, May 17, 2021 /PRNewswire-PRWeb/ --The implementation process for rapid molecular blood culture identification can be a complex process for laboratories, medical staff and the antimicrobial stewardship program (ASP).
  • There can be many facets of the process that can easily sink below the surface, which is where GenMark Diagnostics endeavors to ensure a smooth process.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.\nAyesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]\n'

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, April 12, 2021
Health sciences, Lincosamides, Antimicrobial, Infection, Antibiotic, Life sciences, Health, Antibiotic resistance, Pharmaceuticals policy, Veterinary medicine

b'The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal associations.

Key Points: 
  • b'The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal associations.
  • The infectious diseases segment accounted for the largest share of the market.
  • The veterinary hospitals segment holds the largest share in the companion animal pharmaceuticals market due to the higher adoption of animal parasiticides and antibiotics in hospital settings, increasing incidence of infectious diseases, growing number of veterinary hospitals, growing ownership of companion animals, increasing veterinary expenditure, and growing awareness about animal health in developing countries.\nThe companion animal pharmaceuticals market in the APAC region is expected to register the highest CAGR during the forecast period.
  • Ltd. (India).\nAnimal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026\n'

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, April 12, 2021
Health sciences, Lincosamides, Antimicrobial, Infection, Antibiotic, Life sciences, Health, Antibiotic resistance, Pharmaceuticals policy, Veterinary medicine

b'The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal associations.

Key Points: 
  • b'The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal associations.
  • The infectious diseases segment accounted for the largest share of the market.
  • The veterinary hospitals segment holds the largest share in the companion animal pharmaceuticals market due to the higher adoption of animal parasiticides and antibiotics in hospital settings, increasing incidence of infectious diseases, growing number of veterinary hospitals, growing ownership of companion animals, increasing veterinary expenditure, and growing awareness about animal health in developing countries.\nThe companion animal pharmaceuticals market in the APAC region is expected to register the highest CAGR during the forecast period.
  • Ltd. (India).\nAnimal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026\n'

Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market

Retrieved on: 
Thursday, April 8, 2021
Health sciences, Livestock, Health, Branches of biology, Antibiotic resistance, Meat industry, Pharmaceuticals policy, Veterinary medicine, Antibiotic use in livestock, Probiotic, Animal feed, Antibiotic

For further information on Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration, please visit: http://frost.ly/5fc

Key Points: 
  • For further information on Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration, please visit: http://frost.ly/5fc
    "Amino acids dominate the global industry and are expected to remain in the top position, generating revenues of $11.5 billion by 2026.
  • The ever-growing demand for high-quality meat has forced livestock farmers to also fortify animal feed with vitamins, organic acids, enzymes, and probiotics.
  • "As farmers gradually reduce and discontinue the use of antibiotic growth promoters, the rising demand for its alternatives creates new revenue streams for manufacturers in this space."
  • Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration is the latest addition to Frost & Sullivan's Chemicals, Materials and Nutrition research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market

Retrieved on: 
Thursday, April 8, 2021
Health sciences, Livestock, Health, Branches of biology, Antibiotic resistance, Meat industry, Pharmaceuticals policy, Veterinary medicine, Antibiotic use in livestock, Probiotic, Animal feed, Antibiotic

For further information on Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration, please visit: http://frost.ly/5fc

Key Points: 
  • For further information on Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration, please visit: http://frost.ly/5fc
    "Amino acids dominate the global industry and are expected to remain in the top position, generating revenues of $11.5 billion by 2026.
  • The ever-growing demand for high-quality meat has forced livestock farmers to also fortify animal feed with vitamins, organic acids, enzymes, and probiotics.
  • "As farmers gradually reduce and discontinue the use of antibiotic growth promoters, the rising demand for its alternatives creates new revenue streams for manufacturers in this space."
  • Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration is the latest addition to Frost & Sullivan's Chemicals, Materials and Nutrition research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.